Outcomes from a phase I trial of an adenovirus/PSA vaccine for prostate cancer

被引：3
|
作者：
Lubaroff, David M.
Konety, Badrinath R.
Link, Brian K.
Ratliff, Timothy L.
Madsen, Tammy
Williams, Richard D.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60534-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [31] Treatment planning for a phase 1 trial of PSA-activated PSA-PAH1 for prostate cancer
    Boyer, A.
    Culp, L.
    Mistry, V.
    Kuehl, T.
    Runge, V.
    Milleman, J.
    Coffeld, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S679 - S679
  • [32] Time to biochemical and radiographic progression in patients treated with adenovirus-PSA vaccine for non-metastatic/early metastatic castrate-resistant prostate cancer: Phase 2 trial results.
    Vaena, Daniel A.
    Nepple, Kenneth Gerard
    Brown, James A.
    Griffith, Karen
    Zehr, Pamela
    Lubaroff, David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer
    Douglas G. McNeel
    Heath A. Smith
    Jens C. Eickhoff
    Joshua M. Lang
    Mary Jane Staab
    George Wilding
    Glenn Liu
    Cancer Immunology, Immunotherapy, 2012, 61 : 1137 - 1147
  • [34] Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer
    McNeel, Douglas G.
    Smith, Heath A.
    Eickhoff, Jens C.
    Lang, Joshua M.
    Staab, Mary Jane
    Wilding, George
    Liu, Glenn
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (07) : 1137 - 1147
  • [35] Preoperative PSA kinetics predict prostate cancer outcomes
    Caroline Barranco
    Nature Clinical Practice Urology, 2006, 3 (2): : 64 - 65
  • [36] 125I versus 103Pd for low-risk prostate cancer:: Preliminary PSA outcomes from a prospective randomized multicenter trial
    Wallner, K
    Merrick, G
    True, L
    Sutlief, S
    Cavanagh, W
    Butler, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05): : 1297 - 1303
  • [37] Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer
    Freytag, Svend O.
    Movsas, Benjamin
    Aref, Ibrahim
    Stricker, Hans
    Peabody, James
    Pegg, Jan
    Zhang, Yingshu
    Barton, Kenneth N.
    Brown, Stephen L.
    Lu, Mei
    Savera, Adnan
    Kim, Jae Ho
    MOLECULAR THERAPY, 2007, 15 (05) : 1016 - 1023
  • [38] Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial
    Murtola, Teemu J.
    Tammela, Teuvo L. J.
    Maattanen, Liisa
    Huhtala, Heini
    Platz, Elizabeth A.
    Ala-Opas, Martti
    Stenman, Ulf-Hakan
    Auvinen, Anssi
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) : 1650 - 1659
  • [39] Prostate cancer vaccine Prostvac successful in phase 1 trial with checkpoint inhibitor
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 808 - 808
  • [40] Follow-up evaluation of a phase II prostate cancer vaccine trial
    Tjoa, BA
    Simmons, SJ
    Elgamal, A
    Rogers, M
    Ragde, H
    Kenny, GM
    Troychak, MJ
    Boynton, AL
    Murphy, GP
    PROSTATE, 1999, 40 (02): : 125 - 129
12345